Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

NURR1 Impairment in Multiple Sclerosis.

Montarolo F, Martire S, Perga S, Bertolotto A.

Int J Mol Sci. 2019 Sep 30;20(19). pii: E4858. doi: 10.3390/ijms20194858. Review.

2.

Immunomodulatory Effect of Pregnancy on Leukocyte Populations in Patients With Multiple Sclerosis: A Comparison of Peripheral Blood and Decidual Placental Tissue.

Spadaro M, Martire S, Marozio L, Mastromauro D, Montanari E, Perga S, Montarolo F, Brescia F, Balbo A, Botta G, Benedetto C, Bertolotto A.

Front Immunol. 2019 Aug 16;10:1935. doi: 10.3389/fimmu.2019.01935. eCollection 2019.

3.

NURR1 deficiency is associated to ADHD-like phenotypes in mice.

Montarolo F, Martire S, Perga S, Spadaro M, Brescia I, Allegra S, De Francia S, Bertolotto A.

Transl Psychiatry. 2019 Aug 27;9(1):207. doi: 10.1038/s41398-019-0544-0.

4.

Study of the NR4A family gene expression in patients with multiple sclerosis treated with Fingolimod.

Montarolo F, Perga S, Martire S, Brescia F, Caldano M, Lo Re M, Panzica G, Bertolotto A.

Eur J Neurol. 2019 Apr;26(4):667-672. doi: 10.1111/ene.13875. Epub 2018 Dec 22.

PMID:
30565812
5.

Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.

Mancini C, Hoxha E, Iommarini L, Brussino A, Richter U, Montarolo F, Cagnoli C, Parolisi R, Gondor Morosini DI, Nicolò V, Maltecca F, Muratori L, Ronchi G, Geuna S, Arnaboldi F, Donetti E, Giorgio E, Cavalieri S, Di Gregorio E, Pozzi E, Ferrero M, Riberi E, Casari G, Altruda F, Turco E, Gasparre G, Battersby BJ, Porcelli AM, Ferrero E, Brusco A, Tempia F.

Neurobiol Dis. 2019 Apr;124:14-28. doi: 10.1016/j.nbd.2018.10.018. Epub 2018 Oct 30.

PMID:
30389403
6.

Emerging roles of Fgf14 in behavioral control.

Hoxha E, Marcinnò A, Montarolo F, Masante L, Balbo I, Ravera F, Laezza F, Tempia F.

Behav Brain Res. 2019 Jan 1;356:257-265. doi: 10.1016/j.bbr.2018.08.034. Epub 2018 Sep 3.

PMID:
30189289
7.

The Footprints of Poly-Autoimmunity: Evidence for Common Biological Factors Involved in Multiple Sclerosis and Hashimoto's Thyroiditis.

Perga S, Martire S, Montarolo F, Giordani I, Spadaro M, Bono G, Corvisieri S, Messuti I, Panzica G, Orlandi F, Bertolotto A.

Front Immunol. 2018 Feb 20;9:311. doi: 10.3389/fimmu.2018.00311. eCollection 2018.

8.

The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.

Castellano I, Metovic J, Balmativola D, Annaratone L, Rangel N, Vissio E, Arisio R, Macrì L, Pecchioni C, Sarotto I, Montarolo F, Muscarà F, Marchiò C, Cassoni P, Kulka J, Sapino A.

PLoS One. 2017 Aug 14;12(8):e0182073. doi: 10.1371/journal.pone.0182073. eCollection 2017.

9.

Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients.

Spadaro M, Montarolo F, Perga S, Martire S, Brescia F, Malucchi S, Bertolotto A.

Clin Immunol. 2017 Aug;181:83-88. doi: 10.1016/j.clim.2017.06.006. Epub 2017 Jun 19.

PMID:
28642148
10.

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)-from morphology to molecular testing.

Righi L, Franzi F, Montarolo F, Gatti G, Bongiovanni M, Sessa F, La Rosa S.

J Thorac Dis. 2017 May;9(Suppl 5):S395-S404. doi: 10.21037/jtd.2017.03.158. Review.

11.

A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

Perga S, Martire S, Montarolo F, Navone ND, Calvo A, Fuda G, Marchet A, Leotta D, Chiò A, Bertolotto A.

Neurotox Res. 2017 Jul;32(1):1-7. doi: 10.1007/s12640-017-9724-y. Epub 2017 Mar 23.

12.

Erratum to: Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Montarolo F, Perga S, Martire S, Navone DN, Marchet A, Leotta D, Bertolotto A.

Neurotox Res. 2017 Feb;31(2):317. doi: 10.1007/s12640-016-9685-6. No abstract available.

PMID:
27913963
13.

Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse.

Pellegrino RM, Boda E, Montarolo F, Boero M, Mezzanotte M, Saglio G, Buffo A, Roetto A.

Sci Rep. 2016 Aug 1;6:30725. doi: 10.1038/srep30725.

14.

Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.

Montarolo F, Perga S, Martire S, Navone DN, Marchet A, Leotta D, Bertolotto A.

Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9. Erratum in: Neurotox Res. 2016 Dec 2;:.

PMID:
27159982
15.

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.

Martire S, Navone ND, Montarolo F, Perga S, Bertolotto A.

J Neuroimmunol. 2016 Mar 15;292:34-9. doi: 10.1016/j.jneuroim.2016.01.010. Epub 2016 Jan 16.

PMID:
26943956
16.

Nurr1 reduction influences the onset of chronic EAE in mice.

Montarolo F, Perga S, Martire S, Bertolotto A.

Inflamm Res. 2015 Nov;64(11):841-4. doi: 10.1007/s00011-015-0871-4. Epub 2015 Sep 4.

PMID:
26337347
17.

Anti-inflammatory genes associated with multiple sclerosis: a gene expression study.

Perga S, Montarolo F, Martire S, Berchialla P, Malucchi S, Bertolotto A.

J Neuroimmunol. 2015 Feb 15;279:75-8. doi: 10.1016/j.jneuroim.2015.01.004. Epub 2015 Jan 21.

18.

Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.

Montarolo F, Raffaele C, Perga S, Martire S, Finardi A, Furlan R, Hintermann S, Bertolotto A.

PLoS One. 2014 Sep 29;9(9):e108791. doi: 10.1371/journal.pone.0108791. eCollection 2014.

19.

Early enriched environment exposure protects spatial memory and accelerates amyloid plaque formation in APP(Swe)/PS1(L166P) mice.

Montarolo F, Parolisi R, Hoxha E, Boda E, Tempia F.

PLoS One. 2013 Jul 24;8(7):e69381. doi: 10.1371/journal.pone.0069381. Print 2013.

20.

A de novo X;8 translocation creates a PTK2-THOC2 gene fusion with THOC2 expression knockdown in a patient with psychomotor retardation and congenital cerebellar hypoplasia.

Di Gregorio E, Bianchi FT, Schiavi A, Chiotto AM, Rolando M, Verdun di Cantogno L, Grosso E, Cavalieri S, Calcia A, Lacerenza D, Zuffardi O, Retta SF, Stevanin G, Marelli C, Durr A, Forlani S, Chelly J, Montarolo F, Tempia F, Beggs HE, Reed R, Squadrone S, Abete MC, Brussino A, Ventura N, Di Cunto F, Brusco A.

J Med Genet. 2013 Aug;50(8):543-51. doi: 10.1136/jmedgenet-2013-101542. Epub 2013 Jun 7.

21.

Motor dysfunction and cerebellar Purkinje cell firing impairment in Ebf2 null mice.

Hoxha E, Tonini R, Montarolo F, Croci L, Consalez GG, Tempia F.

Mol Cell Neurosci. 2013 Jan;52:51-61. doi: 10.1016/j.mcn.2012.09.002. Epub 2012 Sep 18.

22.

Excitability and synaptic alterations in the cerebellum of APP/PS1 mice.

Hoxha E, Boda E, Montarolo F, Parolisi R, Tempia F.

PLoS One. 2012;7(4):e34726. doi: 10.1371/journal.pone.0034726. Epub 2012 Apr 12.

23.

Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease.

Boda E, Hoxha E, Pini A, Montarolo F, Tempia F.

J Mol Neurosci. 2012 Mar;46(3):606-15. doi: 10.1007/s12031-011-9648-6. Epub 2011 Sep 13.

24.

Morphological and biomolecular characterization of the neonatal olfactory bulb ensheathing cell line.

Audisio C, Raimondo S, Nicolino S, Gambarotta G, Di Scipio F, Macrì L, Montarolo F, Giacobini-Robecchi MG, Porporato P, Filigheddu N, Graziani A, Geuna S, Perroteau I.

J Neurosci Methods. 2009 Dec 15;185(1):89-98. doi: 10.1016/j.jneumeth.2009.09.021. Epub 2009 Sep 26.

Supplemental Content

Loading ...
Support Center